CPRX
Catalyst Pharmaceuticals Inc
31.50$
+0.0%
vs. previous close
Closing price · As of: Jul 21, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +46.7% | +23.3% | -42.6% | +100.9% | +13.6% | -2.7% | -15.3% | +18.7% | -54.5% | +38.4% | +32.7% | – | |
| – | 0.0% | +6.7% | +3.1% | +0.1% | +0.2% | +0.1% | +0.0% | +0.0% | -0.5% | +1.3% | +2.5% | – | |
| – | +15.5% | +11.5% | +94.1% | -46.6% | +0.4% | +16.9% | +13.1% | +29.9% | -25.4% | -0.2% | +10.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -213.0% | – | +206.1% | -83.2% | -258.6% | – | -4,288.5% | – | – | – | |
| – | – | +3,521.9% | -91.4% | -95.0% | +2,490.0% | -66.0% | -100.0% | – | -100.0% | – | -15.6% | – | |
| – | – | -58.7% | -99.5% | -95.0% | +2,490.0% | -66.0% | – | – | – | – | -15.6% | – | |
| – | -100.0% | – | -34.7% | -100.0% | – | -100.0% | – | – | – | – | -42.4% | – | |
| – | +4,632.2% | -93.4% | – | -99.2% | -616.3% | – | -31.0% | -71.5% | +433.7% | -649.6% | -49.7% | – | |
| – | -289.3% | – | +936.8% | -62.2% | +2.1% | +12.9% | -16.1% | +14.3% | -48.6% | -48.0% | +142.2% | – | |
| – | +46.5% | +18.3% | -40.5% | +102.1% | +13.2% | -2.5% | -15.2% | +18.7% | -54.5% | +38.3% | +32.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.